AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 APR 1 - (NewsRx.com & NewsRx.net) -- The GENESIS Network for Reproductive Health, an independent group of fertility specialists, received a grant to study the role that preimplantation genetic diagnosis (PGD) combined with in-vitro fertilization (IVF) plays in reducing multiple births.
Dr. Lawrence Werlin, the study's principal investigator and cofounder of GENESIS, announced the grant, entitled "Preimplantation Genetic Diagnosis as a Tool to Lower Multifetal Pregnancy Rates."
The study responds to research indicating that multiple births in the United States are alarmingly high with a noted increase of 59% in the last 2 decades. The Centers for Disease Control and Prevention reports an estimated two-thirds of triplet or higher births are the result of fertility-enhancing therapies. Research also indicates that the trend and rate increase will continue.
PGD is a therapeutic and genetic testing tool that aids in the IVF process by screening for abnormal chromosomes or genetic ...